NCT02183831

Brief Summary

This study was set up to identify clinical outcomes including a refractive shift or change in IOL calculation accuracy and optical quality after Ophtec® capsular tension ring in the eyes without zonular instability.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2014

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

June 23, 2014

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 8, 2014

Completed
Last Updated

July 8, 2014

Status Verified

June 1, 2014

Enrollment Period

1 month

First QC Date

June 23, 2014

Last Update Submit

July 2, 2014

Conditions

Outcome Measures

Primary Outcomes (4)

  • Best corrected visual acuity

    Visual acuity measurement using refractive error correction

    1 month after capsular tension ring and intraocular lens implantation (cataract surgery) using capsular tension ring

  • refractive error

    Autokeratometry (KR-7100; Topcon, Tokyo, Japan) and manifested refraction were performed to examine refractive errors

    1 month after capsular tension ring and intraocular lens implantation (cataract surgery) using capsular tension ring

  • Anterior chamber depth

    obtained with a Scheimpflug imaging system (Pentacam; OCULUS Optikgeräte GmbH, Wetzlar, Germany)

    3 months after capsular tension ring and intraocular lens implantation (cataract surgery) using capsular tension ring

  • Ocular aberrations

    measured using the ray-tracing aberrometer (iTrace, Tracey Technologies, Houston, TX, USA) at a pupil size of 5 mm in mesopic conditions, without pharmacologic dilatation

    1month after capsular tension ring and intraocular lens implantation (cataract surgery) using capsular tension ring

Secondary Outcomes (5)

  • constrast sensitivity

    3 months after capsular tension ring and intraocular lens implantation (cataract surgery) using capsular tension ring

  • posterior capsular opacity grades

    3 months after capsular tension ring and intraocular lens implantation (cataract surgery) using capsular tension ring

  • Best corrected visual acuity

    3 months after capsular tension ring and intraocular lens implantation (cataract surgery) using capsular tension ring

  • refractive error

    3 months after capsular tension ring and intraocular lens implantation (cataract surgery) using capsular tension ring

  • Ocular aberrations

    3 months after capsular tension ring and intraocular lens implantation (cataract surgery) using capsular tension ring

Study Arms (2)

Capsular tension ring non insertion group

The patients who had same cataract surgery procedure without CTR insertion

Capsular tension ring insertion group

The patients who underwent capsular tension ring insertion just before IOL implantation during cataract surgery

Device: Insertion of the capsular tension ring

Interventions

Also known as: a pre-loaded CTR in single use injector was inserted just before IOL implantation during cataract surgery
Capsular tension ring insertion group

Eligibility Criteria

Age40 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The patients who were planned to undergo the cataract surgery in Department of Ophthalmology, Yonsei University College of Medicine

You may qualify if:

  • age between 40 and 79 years
  • no history of eye surgery or glaucoma
  • a transparent central cornea
  • pupil dilation at the preoperative examination of at least 6.0 mm
  • absence of biomicroscopic signs of pseudoexfoliation
  • normal fundus examination

You may not qualify if:

  • presence of ocular disease that might affect the visual outcome (e.g., color vision disturbance, chronic uveitis)
  • presence of ocular disease that might affect contrast sensitivity function (e.g., glaucoma, maculopathy, high myopia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2014

First Posted

July 8, 2014

Study Start

May 1, 2014

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

July 8, 2014

Record last verified: 2014-06